Difference between revisions of "Vascular sarcoma"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "<big>" to "") |
Warner-admin (talk | contribs) m (Text replacement - "</big>" to "") |
||
| Line 10: | Line 10: | ||
|} | |} | ||
'''Note: this page does not contain any regimens. The following links will take you to disease-specific pages with regimens:''' | '''Note: this page does not contain any regimens. The following links will take you to disease-specific pages with regimens:''' | ||
| − | *Regimens for [[Angiosarcoma|'''Angiosarcoma''' are here]] | + | *Regimens for [[Angiosarcoma|'''Angiosarcoma''' are here]]. |
| − | *Regimens for [[Kaposi sarcoma|'''Kaposi sarcoma''' are here]] | + | *Regimens for [[Kaposi sarcoma|'''Kaposi sarcoma''' are here]]. |
{{TOC limit|limit=3}} | {{TOC limit|limit=3}} | ||
=Guidelines= | =Guidelines= | ||
Latest revision as of 00:25, 4 July 2024
| Section editor | |
|---|---|
 |
Elizabeth J. Davis, MD Vanderbilt University Nashville, TN, USA |
0 regimens on this page
0 variants on this page
|
Note: this page does not contain any regimens. The following links will take you to disease-specific pages with regimens:
- Regimens for Angiosarcoma are here.
- Regimens for Kaposi sarcoma are here.
Guidelines
Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only.
ESMO
- Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2014) PubMed